PRECLINICAL DEVELOPMENT

EACH LEAD CANDIDATE IS REFINED, OPTIMIZED AND TESTED EXTENSIVELY TO PROVIDE SUFFICIENT EVIDENCE OF SAFETY AND EFFECTIVENESS BEFORE IT CAN ADVANCE INTO CLINICAL TESTING IN HUMANS.

Before clinical trials can begin, teams must scale-up production to ensure an adequate supply of the investigation candidate for clinical trials. This means scaling up production from small batches made in the labs to larger scale quantities formulated for clinical use in people.